This post was originally published on this site
Among the positive factors, Pfizer Inc. (NYSE:PFE) announced on November 5 that its COVID-19 antiviral pill, when used with a widely used HIV drug, cut the risk of hospitalization or death from COVID-19 by 89% in high-risk adults who’ve been exposed to the virus. U.S. jobless claims declined to a 267,000 pandemic low. And, according to a Factset report, the S&P 500 reported the second-highest revenue growth in the third quarter since 2008. These factors have helped boost investor sentiment.
Given this backdrop, we think it could be wise to add fundamentally sound stocks Lufax Holding Ltd. (LU), Companhia Siderúrgica Nacional (SID), and Brinker International, Inc. (EAT) to one’s portfolio. They have declined by more than 20% in price year-to-date but are well-positioned to rebound in the coming months.
